Management of pace-terminated ventricular arrhythmias.

Journal Article (Journal Article;Review)

An implantable-cardioverter defibrillator (ICD) can terminate ventricular arrhythmias by delivering a shock or by antitachycardia pacing (ATP). The ATP works by capturing the excitable gap and disrupting re-entrant ventricular arrhythmias. Multiple studies have demonstrated that ATP is successful at terminating ventricular tachycardia (VT). Shocks from the ICD are associated with higher mortality. The data are conflicting about whether appropriate ATP is associated with higher mortality. In a patient with VT that is treated by ATP, the patient's guideline-based heart failure medications should be maximized. The use of VT ablation after appropriate and successful ATP requires additional studies.

Full Text

Duke Authors

Cited Authors

  • Pokorney, SD; Al-Khatib, SM

Published Date

  • September 2015

Published In

Volume / Issue

  • 7 / 3

Start / End Page

  • 497 - 513

PubMed ID

  • 26304530

Electronic International Standard Serial Number (EISSN)

  • 1877-9190

Digital Object Identifier (DOI)

  • 10.1016/j.ccep.2015.05.009


  • eng

Conference Location

  • United States